NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MARS Bioimaging

MARS Bioimaging

Private
ChristchurchHealthcare & Life Scienceshttps://www.marsbioimaging.com/

Last Round

Series A

Jan 14, 2026

Total Funding Raised

$42.36M

Company Overview

MARS Bioimaging is a medical device company that develops and manufactures spectral photon-counting computed tomography (CT) scanners which produce quantitative 3D color x-ray images for pre-clinical research and clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

spectral CTphoton-counting CTspectral imagingmicro-CTcolor CTspectral molecular imagingMedipixcolor X-raypreclinical imagingCT scannercomputed tomographybiomedical imagingcomputational imagingmaterial decompositionmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MARS Bioimaging Comparables

Compare MARS Bioimaging with similar companies based on industry and business-model similarity.

MARS Bioimaging comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SCANCO Medical AG
83%
TriFoil Imaging
83%
Rigaku Holdings Corporation
78%

MARS Bioimaging Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 14, 2026
GrantNov 1, 2014
SeedFeb 25, 2014

Key People

Founding team and executive leadership

Ojas Mahapatra

Group Chief Executive Officer

Executive Team

Anthony Butler

Chief Technology Officer

Executive Team

Rob Campbell CMInstD

Chief Financial Officer

Executive Team

Mark Figgitt

Group COO

Executive Team

MARS Bioimaging Investors

Notable investors and investment history

MARS Bioimaging Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MARS Bioimaging Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MARS Bioimaging's valuation, stock price, and market status.

Firmographic Details

HeadquartersChristchurch
Employee Range25
Year Founded2007
Last FundingJan 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.